⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3852475 | 1.00 | — | — | |
| SCHEMBL23439640 | 0.77 | — | — | |
| SCHEMBL11472770 | 0.77 | — | — | |
| SCHEMBL11472772 | 0.77 | — | — | |
| SCHEMBL18897929 | 0.76 | — | — | |
| SCHEMBL446127 | 0.71 | — | — | |
| SCHEMBL2142076 | 0.71 | — | — | |
| SCHEMBL446126 | 0.71 | — | — | |
| SCHEMBL19886275 | 0.71 | — | — | |
| SCHEMBL3586589 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279420-A1 | POLYOL BLENDED LIQUID COMPOSITION FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN BLOWN POLYURETHANE FOAM, AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2024-08-22 | — | — | US | claimed |
| WO-2022239734-A1 | POLYOL-BASED MIXED LIQUID COMPOSITION FOR PRODUCING HYDROCHLOROFUROOLEFIN FOAMED POLYURETHANE FOAM, AND USE THEREOF | 東ソー株式会社 | 2022-11-17 | — | — | WO | claimed |
| US-20240279420-A1 | POLYOL BLENDED LIQUID COMPOSITION FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN BLOWN POLYURETHANE FOAM, AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2024-08-22 | — | — | US | disclosed |
| WO-2022239734-A1 | POLYOL-BASED MIXED LIQUID COMPOSITION FOR PRODUCING HYDROCHLOROFUROOLEFIN FOAMED POLYURETHANE FOAM, AND USE THEREOF | 東ソー株式会社 | 2022-11-17 | — | — | WO | disclosed |
| EP-2087910-B1 | Polymeric prodrugs | ASCENDIS PHARMA GMBH (DE) | 2022-05-04 | — | — | EP | disclosed |
| US-20210283264-A1 | Polymeric Prodrugs with a Self-Immolative Linker | ASCENDIS PHARMA GMBH (DE) | 2021-09-16 | — | — | US | disclosed |
| EP-1732607-B1 | POLYMERIC PRODRUG WITH A SELF-IMMOLATIVE LINKER | ASCENDIS PHARMA GMBH (DE) | 2019-05-15 | — | — | EP | disclosed |
| US-20160089448-A1 | POLYMERIC PRODRUG WITH A SELF-IMMOLATIVE LINKER | ASCENDIS PHARMA GMBH (DE) | 2016-03-31 | — | — | US | disclosed |
| US-9238686-B2 | Polymeric prodrug with self-immolative linker | ASCENDIS PHARMA GMBH (DE) | 2016-01-19 | — | — | US | disclosed |
| US-20130150281-A1 | POLYMERIC PRODRUG WITH SELF-IMMOLATIVE LINKER | ASCENDIS PHARMA GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| US-8377917-B2 | Polymeric prodrug with a self-immolative linker | COMPLEX BIOSYSTEMS GMBH (DE) | 2013-02-19 | — | — | US | disclosed |
| EP-2087910-A2 | Polymeric prodrugs | Complex Biosystems GmbH (DE) | 2009-08-12 | — | — | EP | disclosed |
| US-20080241102-A1 | Polymeric Prodrug with a Self-Immolative Linker | COMPLEX BIOSYSTEMS GMBH (DE) | 2008-10-02 | — | — | US | disclosed |
| US-7384952-B2 | Pyrazolopyrimidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-06-10 | — | — | US | disclosed |
| EP-1857459-A2 | Pyrazolopyrimidine compound and a process for preparing the same | TANABE SEIYAKU CO., LTD. (JP) | 2007-11-21 | — | — | EP | disclosed |
| EP-1732607-A2 | POLYMERIC PRODRUG WITH A SELF-IMMOLATIVE LINKER | Complex Biosystems GmbH (DE) | 2006-12-20 | — | — | EP | disclosed |
| US-20060135525-A1 | Pyrazolopyrimidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-1625855-A1 | Polymeric prodrug with a self-immolative linker | Complex Biosystems GmbH (DE) | 2006-02-15 | — | — | EP | disclosed |
| WO-2005099768-A2 | POLYMERIC PRODRUG WITH A SELF-IMMOLATIVE LINKER | COMPLEX BIOSYSTEMS GMBH (DE) | 2005-10-27 | — | — | WO | disclosed |